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ABSTRACT
T-STAG (tissue-specific transcripts and genes) is a
resource and web-interface, designated to analyze
tissue/tumor-specific expression patterns in human
and mouse transcriptomes. It integrates our refined
prediction of specific expression patterns both in
genes as well as in individual isoforms with man–
mouse orthology data. In combination with the fea-
tures forcombining/contrastingthe genes expressed
indifferenttissues, T-STAG implicatesimportantbio-
logical applications, such as the detection of differ-
entially expressed genes in tumors, the retrieval of
orthologs with significant expression in the same tis-
sue etc. Additionally, our refined categorization of
expressedsequencetags(ESTs)accordingtothenor-
malization of cDNA libraries allows searching for
putative low-abundant transcripts. The results are
tightly linked to our visualization tools, GeneNest
(expression patterns of genes) and SpliceNest (gene
structure and alternative splicing). The user-friendly
interfaceofT-STAGoffersaplatformforcomprehens-
ive analysis of tissue and/or tumor-specific expres-
sion patterns revealed by the EST data. T-STAG is
freely accessible at http://tstag.molgen.mpg.de.
INTRODUCTION
The complex differences in protein pools related to different
cell types are a result of variation in the interpretation of the
same genomic sequence. This variation is caused by various
regulatory control mechanisms operating at transcriptional,
post-transcriptional, translational and post-translational level.
At the transcriptional level, control is achieved via transcrip-
tion factors (1,2), which recognize certain cis-regulatory ele-
ments of the target genes and modulate their expression,
occasionally in a tissue-speciﬁc manner (3,4). An additional
regulatory mechanism is alternative splicing, which is con-
trolled by exonic and intronic enhancers/silencers that allow
differential expression of alternative mRNAs from the same
primary transcript (5,6). Sometimes this mechanism also oper-
ates in a tissue-speciﬁc manner (7). Anomalous expression of
the genes involved intheseregulatorymechanismsisknownto
result in diseases (8,9).
Among the most popular methods to estimate and analyze
expression patterns are serial analysis of gene expression
[SAGE (10)] and expressed sequence tags [ESTs (11)]
based methods. While both SAGE and ESTs are useful for
analyzing expression patterns of genes [electronic northern
(12)], a fraction of ESTs that cover isoform-speciﬁc parts
[ASD (13), MAASE (14), ASAP (15) and SpliceNest (16)]
also enable the detection of tissue/tumor speciﬁc alternative
isoforms (17,18). However, the congruence between EST
coverage and expression pattern is disturbed due to varying
experimental protocols of EST generation (19), thereby
implicating the need for a more reﬁned methodology for
estimating expression levels (20).
In the this paper, we describe T-STAG (tissue-speciﬁc tran-
scripts and genes), a resource and web-interface, which inte-
grates predictions of speciﬁc expression patterns of both genes
as well as of individual isoforms, thus allowing to address
additional or more specialized biological questions. Our
detailed categorization of ESTs (normalized, disease related),
the features to compare subsets of genes and the integration of
tissue speciﬁc genes/isoforms implicate a wide range of appli-
cations. Among these are the detection of expression patterns
of low-abundant transcripts and the identiﬁcation of differen-
tial expression of genes in tumors. Above all, it allows for
contrasting the tissue-speciﬁcally expressed isoforms with the
background expression of all isoforms of the respective gene.
The additional integration of man–mouse orthology data
enables the comparison of expression proﬁles in orthologous
genes. In combination with the user-friendly web-interface,
T-STAG offers a platform for comprehensive analyses of
expression patterns of genes as well as individual isoforms.
METHODS
T-STAG (http://tstag.molgen.mpg.de) is designed for detailed
investigation of tissue/tumor speciﬁc expression in genes and
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are integrated via the web-database.
Gene expression estimates. The EST clusters (genes) and
the annotation of EST libraries is derived from GeneNest
database based on Unigene build 161 (August 2003) for
human and Unigene build 118 (December 2002) for mouse
(21). The tissue distribution of ESTs in a cluster relative to
random background is translated into numerical estimates
(P-values) of the likelihood of observing such a tissue distri-
bution by chance (Haas, S. A. et al., manuscript in prepara-
tion). Therefore, a low P-value for a given gene–tissue pair
reﬂects either signiﬁcant and/or speciﬁc expression of the gene
in the respective tissue.
Transcript expression data. The GeneNest (22) consensus
sequences are mapped to the genome sequence (Human: April
2003 freeze of HUGO and Mouse: February 2002 freeze from
the Mouse Genome Sequencing Consortium) and alternative
isoforms are predicted with conﬁdence values, using the EST
coverage and splice signal indicators as a measure of reliab-
ility [SpliceNest (16,23)]. Parts of these putative transcripts
that are speciﬁcally covered either by ESTs related to a single
tissue or only by ESTs derived from tumor-related libraries
are then labeled as tissue- or tumor-speciﬁc splice events,
respectively (20).
Man–mouse orthologs. The human and mouse protein
sequences are taken from RefSeq. Pairs of sequences with
best bidirectional PBLAST alignment scores are deﬁned as
orthologs. The corresponding mRNA sequences are then
inferred using TBLASTN of protein sequences with the
respective reference sequences, thereby providing a link to
the Unigene clusters.
Finally, the gene expression estimates, the transcript expres-
sion data and the man–mouse ortholog data is integrated via a
relational database system (postgres). In order to enhance the
practical applicability of the resource, a user-friendly web
interface (Figure 1) is designed with download option to
facilitate integration of the data into external applications.
RESULTS AND DISCUSSION
Tissue-specific expression of genes and splice isoforms
Tissue-speciﬁc regulation of gene/isoform expression is
known to play critical functional roles as in the case of
many known genes, such as complement regulator CD46
(24) and phosphodiesterase [PDE7 (25)], apart from being
associated with certain general mechanisms [tissue-speciﬁc
RNA surveillance (26)]. The tissue-speciﬁc genes identiﬁed
via the T-STAG database frequently include several known
ones,asinthecaseofeye-speciﬁcgenes,inwhich 19outofthe
top 20 have already been described to be functionally related
to eye (e.g. rhodopsin, crystallin, opticin etc.). A similar evalu-
ation performed for alternative isoforms also revealed a num-
ber of already known tissue-speciﬁc splice events among the
top ranking matches. For example, most of the known genes
containingputativekidney-speciﬁc transcriptsare experiment-
ally described to contain kidney-related isoforms [AFP (27),
SLC22A8 (28), WNK1 (29), GLS (30)]. The so far unannotated
tissue-speciﬁc genes/isoforms with signiﬁcant EST evidence
need to be further analyzed, some of which after being
screened for functional and/or possibly tissue-speciﬁc
domains could be (partially) annotated.
Rare genes/alternative isoforms and disease-related
genes/isoforms
The EST data provides an estimate of the low-abundant genes/
isoforms by the virtue of the differing protocols of EST
Figure 1. The T-STAG query interface. The interface is arranged in three main sections: (i) basic information and chromosomal location: various gene identities,
accessions, keywords and chromosomal location can be specified. (ii) Splicing information: this can be used to select types of splicing or define a quality cutoff for
alternative splice prediction depending on the particular application. (iii) Tissue information: in this block, the user can specify the tissues of interest. Information
relatedtosecondtissuecanbeusedtospecifyadditionaltissuesinwhichthecandidategenesshould(not)beexpressed.Theorganismcanbeswitchedinordertolook
at human and mouse orthologs. To limit the selection to specifically expressed genes, the number of additional tissues with significant expression can be restricted.
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transcripts in normalized libraries (19), isoforms and genes
that are represented only by such libraries are likely to be
lowly expressed. This property of normalized libraries is uti-
lized in the T-STAG to ﬁlter out those transcripts that are
likely to be lowly expressed. A large fraction of the tissue-
speciﬁc alternative isoforms is observed to be such lowly
expressed ones (20), which even though in low abundance
may still have crucial functions. For example, in one of the
alternative isoforms of gene WNK1, an alternative promoter
controls the expression of a kidney-speciﬁc and kinase-
defective isoform (29).
Owing to our annotation of tumor- and disease-associated
EST libraries, the T-STAG database allows the retrieval of
genes/isoforms that are signiﬁcantly expressed in tumor-or
disease-related tissues. However, in tumor cells an overall
loss of control is observed in different parts of regulation
machinery (31,32), leading to a large number of genes with
abnormal expression levels. Therefore, it is more informative
to focus only on those genes that show signiﬁcant differential
expression in tumors as compared with the normal cell types.
Comparing expression patterns
In order to detect such genes that are differentially expressed
in tumors,in accordance with some microarray-based methods
(33), the predicted tumor-speciﬁc genes can be contrasted with
another set of genes that are signiﬁcantly expressed in the
respective healthy tissue (deﬁned in the form of P-values).
This can be achieved by using the subtraction feature of the
T-STAG database. Several of the top ranking genes revealed
in this fashion are already known cancer-related genes. In
brain tumor, for example, 6 of the top 10 genes have already
been described to be tumor-associated. These include some
genes which are suggested as tumor markers [OLIG1 (34) and
CRF (35)].
Alternatively, by using the addition feature of T-STAG,
anatomically or functionally related tissues can be grouped
together. For example, heart and muscle, for which six
genes with signiﬁcant expression in both tissues are revealed.
Thisset includes titin,which is already knownto play a critical
role for both heart (36) and skeletal muscle (37). In addition,
seemingly non-related pairs of tissues might also have biolo-
gically meaningful set of genes in common. For example, in
the case of eye and pineal gland, we identiﬁed a group of genes
(CRX, OTX2 and PDE6), which are already annotated to be
functionalinbothtissues[PDE6 (38)]. Furthermore,OTX2 isa
known transcription factor that regulates the expression of the
gene CRX both in eye and in pineal gland (39), thereby hinting
toward the existence of a common functional/regulatory path-
way in these tissues. Some of the remaining genes in the
dataset, most of which are currently annotated to be functional
only in eye (such as RCV1, RTDBN, potassium voltage-gated
channel etc.) are therefore potential candidates that may be
regulated by the same molecular mechanism.
With respect to the analysis of individual isoforms, the
addition and subtraction features of the T-STAG database
can be applied to further categorize the tissue-speciﬁc iso-
forms. First of the two categories consists of tissue-speciﬁc
isoforms related to those genes for which other transcripts
show different/ubiquitous expression pattern. Tissue-speciﬁc
expressionobservedinsuchtranscriptsislikelytoberegulated
at the level of splicing (40). In contrast, the second category
comprises tissue-speciﬁc splice events that are observed in
genes, for which all related transcripts are also highly
expressed in the same tissue. These transcripts may reﬂect
tissue-speciﬁc transcription (41,42), rather than tissue-
speciﬁc splicing. Notably, such observations may be biased
due to other post-transcriptional events, such as nonsense-
mediated decay [(NMD) (43)], which might occur with dif-
ferent stringencies in different tissues. In our data, we observe
a large number of tissue-speciﬁc transcripts for both these
categories, e.g. 187 human brain-speciﬁc transcripts poten-
tially undergo speciﬁc alternative splicing, while 91 speciﬁc
transcripts are likely to be the consequence of speciﬁc regu-
lation of entire genes.
Evolutionarily conserved expression patterns
The integration of orthology data with expression data enables
the retrieval of evolutionarily conserved expression patterns in
mouse and human. This provides an additional schema for
deﬁning orthologs in a more stringent fashion. However,
the emergence of expression in additional tissues, like in
the case of gene ACRBP which is expressed only in mouse
testis but is additionally expressed in human brain, may reﬂect
evolution of novel functions.
The web-interface
The interface (Figure 1) is user-friendly and ﬂexible with
possibilities to deﬁne cutoffs (P-values for gene expression,
quality values related to alternative splicing) based on indi-
vidual applications. Additional restricted datasets based on
individual applications can be generated by providing key-
words and/or chromosomal location, thereby enabling queries
like ‘Give me All kinases expressed in human and mouse
brain’. The HTML output provides tight links to the visual-
ization tools, GeneNest (EST resource and visualization) as
well as SpliceNest (gene structure and alternative splice visu-
alization), which allows a detailed inspection of candidate
genes and transcripts.
CONCLUSIONS
T-STAG is a resource and web-interface that allows compre-
hensive evaluation of tissue/tumor-speciﬁc expression both on
the level of genes as well as on the level of individual tran-
scripts. The resource is currently available for human and
mouse with integrated man–mouse orthology data. In com-
bination with the respective gene expression estimates, it pro-
vides an opportunity to compare expression patterns between
orthologous genes. The comparison capability of the resource
resolves the differential expression of genes both with respect
to different tissues and with respect to normal versus tumor
celltypes. T-STAGalso provides opportunity to categorize the
tissue-speciﬁc transcripts that are potentially regulated at the
transcriptional level and those that are likely to be tissue-
speciﬁcally spliced. In essence, coupled with a comprehensive
user-friendly web-interface, the T-STAG aims at serving as a
resource for detailed computational analysis of expression
patterns derived from EST data.
W656 Nucleic Acids Research, 2005, Vol. 33, Web Server issueFuture developments
Future development will include the prediction of develop-
mental stage speciﬁc genes and isoforms. We plan to extend
the database to include other organisms. Additionally, we plan
to compare the EST-based gene expression estimates with
gene expression proﬁles derived from microarray data. The
consensus between these two independent datasets would
provide a platform for the detection of common regulatory
motifs among coexpressed genes.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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